Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Mustafa Çoban, Uğur Bilge, Hale Balseven, Hilmi Uysal & Betül Artut. (2023) The economic evaluation of ALS care: quality and cost. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 502-513.
Read now
Read now
Toni Mora, Raúl Domínguez, Abdelilah Assialioui, Andrés Paipa, Ramon Moreno, Xavier Corbella, Antonio Martínez-Yelamos & Mònica Povedano. (2023) Direct health costs of amyotrophic lateral sclerosis in a multidisciplinary ALS unit in Catalonia (Spain). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 133-138.
Read now
Read now
Lisa Meng, Amy Bian, Scott Jordan, Andrew Wolff, Jeremy M. Shefner & Jinsy Andrews. (2018) Profile of medical care costs in patients with amyotrophic lateral sclerosis in the Medicare programme and under commercial insurance. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:1-2, pages 134-142.
Read now
Read now
Anne Hogden, Geraldine Foley, Robert D Henderson, Natalie James & Samar M Aoun. (2017) Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. Journal of Multidisciplinary Healthcare 10, pages 205-215.
Read now
Read now
Kevin Boylan, Todd Levine, Catherine Lomen-Hoerth, Mary Lyon, Kimberly Maginnis, Peter Callas, Celeste Gaspari & Rup Tandan. (2016) Prospective study of cost of care at multidisciplinary ALS centers adhering to American Academy of Neurology (AAN) ALS practice parameters. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:1-2, pages 119-127.
Read now
Read now
Matthew Gladman & Lorne Zinman. (2015) The economic impact of amyotrophic lateral sclerosis: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 15:3, pages 439-450.
Read now
Read now
Juyeon Oh, Ji Won An, Seong-Il Oh, Ki Wook Oh, Jung A Kim, Jeong Seop Lee & Seung Hyun Kim. (2015) Socioeconomic costs of amyotrophic lateral sclerosis according to staging system. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:3-4, pages 202-208.
Read now
Read now
Sheelah Connolly, Chloe Heslin, Iain Mays, Bernie Corr, Charles Normand & Orla Hardiman. (2015) Health and social care costs of managing amyotrophic lateral sclerosis (ALS): An Irish perspective. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:1-2, pages 58-62.
Read now
Read now
Kostas Athanasakis, Ilias-Ioannis Kyriopoulos, Manthos Sideris, Michael Rentzos, John Evdokimidis & John Kyriopoulos. (2015) Investigating the economic burden of ALS in Greece: A cost-of-illness approach. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:1-2, pages 63-64.
Read now
Read now
Francesco Tramonti, Paolo Bongioanni, Rebecca Leotta, Irene Puppi & Bruno Rossi. (2015) Age, gender, kinship and caregiver burden in amyotrophic lateral sclerosis. Psychology, Health & Medicine 20:1, pages 41-46.
Read now
Read now
Matthew Gladman, Celina Dharamshi & Lorne Zinman. (2014) Economic burden of amyotrophic lateral sclerosis: A Canadian study of out-of-pocket expenses. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:5-6, pages 426-432.
Read now
Read now
Ali Aamer Habib & Hiroshi Mitsumoto. (2011) Emerging drugs for amyotrophic lateral sclerosis. Expert Opinion on Emerging Drugs 16:3, pages 537-558.
Read now
Read now
Articles from other publishers (27)
Munira Essat, Elizabeth Coates, Mark Clowes, Daniel Beever, Gemma Hackney, Sean White, Theocharis Stavroulakis, Vanessa Halliday & Christopher McDermott. (2022) Understanding the current nutritional management for people with amyotrophic lateral sclerosis - A mapping review. Clinical Nutrition ESPEN 49, pages 328-340.
Crossref
Crossref
Lidia García-Pérez, Renata Linertová, Cristina Valcárcel-Nazco, Manuel Posada, Inigo Gorostiza & Pedro Serrano-Aguilar. (2021) Cost-of-illness studies in rare diseases: a scoping review. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
K. Achtert & L. Kerkemeyer. (2021) The economic burden of amyotrophic lateral sclerosis: a systematic review. The European Journal of Health Economics 22:8, pages 1151-1166.
Crossref
Crossref
Alicia Aurora Rodríguez, Óscar Martínez, Imanol Amayra, Juan Francisco López-Paz, Mohammad Al-Rashaida, Esther Lázaro, Patricia Caballero, Manuel Pérez, Sarah Berrocoso, Maitane García, Paula María Luna, Paula Pérez-Núñez & Nicole Passi. (2021) Diseases Costs and Impact of the Caring Role on Informal Carers of Children with Neuromuscular Disease. International Journal of Environmental Research and Public Health 18:6, pages 2991.
Crossref
Crossref
Imen Kacem, Ikram Sghaier, Amina Nasri & Riadh Gouider. 2021. Public Policy in ALS/MND Care. Public Policy in ALS/MND Care
263
278
.
James Grogan & Zachary Simmons. (2020) Telemedicine for the Care of Neuromuscular Disorders. Current Treatment Options in Neurology 22:6.
Crossref
Crossref
Helen Aret Brewah. (2019) A qualitative study of the preparedness of practitioners to care for people with motor neurone disease in their homes. Primary Health Care 29:5, pages 38-44.
Crossref
Crossref
Ileana Howard & Abigail Potts. (2019) Interprofessional Care for Neuromuscular Disease. Current Treatment Options in Neurology 21:8.
Crossref
Crossref
Francesca Morgante, Ganesh Bavikatte, Fahim Anwar & Biju Mohamed. (2019) The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®). Therapeutic Advances in Neurological Disorders 12, pages 175628641988860.
Crossref
Crossref
A. Camacho, J. Esteban & C. Paradas. (2018) Report by the Spanish Foundation for the Brain on the social impact of amyotrophic lateral sclerosis and other neuromuscular disorders. Neurología (English Edition) 33:1, pages 35-46.
Crossref
Crossref
A. Camacho, J. Esteban & C. Paradas. (2018) Informe de la Fundación Del Cerebro sobre el impacto social de la esclerosis lateral amiotrófica y las enfermedades neuromusculares. Neurología 33:1, pages 35-46.
Crossref
Crossref
Nages Nagaratnam, Kujan Nagaratnam & Gary CheukNages Nagaratnam, Kujan Nagaratnam & Gary Cheuk. 2018. Geriatric Diseases. Geriatric Diseases
333
336
.
L.C.G. Lopes, R. Galhardoni, V. Silva, F.M.H. Jorge, L.T. Yeng, D. Callegaro, G. Chadi, M.J. Teixeira & D. Ciampi de Andrade. (2018) Beyond weakness: Characterization of pain, sensory profile and conditioned pain modulation in patients with motor neuron disease: A controlled study. European Journal of Pain 22:1, pages 72-83.
Crossref
Crossref
Sabrina Paganoni, Katie Nicholson, Fawn Leigh, Kathryn Swoboda, David Chad, Kristin Drake, Kellen Haley, Merit Cudkowicz & James D. Berry. (2017) Developing multidisciplinary clinics for neuromuscular care and research. Muscle & Nerve 56:5, pages 848-858.
Crossref
Crossref
Orla Hardiman, Ammar Al-Chalabi, Carol Brayne, Ettore Beghi, Leonard H van den Berg, Adriano Chio, Sarah Martin, Giancarlo Logroscino & James Rooney. (2017) The changing picture of amyotrophic lateral sclerosis: lessons from European registers. Journal of Neurology, Neurosurgery & Psychiatry 88:7, pages 557-563.
Crossref
Crossref
Miriam Galvin, Padhraig Ryan, Sinead Maguire, Mark Heverin, Caoifa Madden, Alice Vajda, Charles Normand & Orla Hardiman. (2017) The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: A population- based study of consultations, interventions and costs. PLOS ONE 12:6, pages e0179796.
Crossref
Crossref
Rachel McCormick & Katarzyna Goljanek-Whysall. 2017. MiRNAs in Aging and Cancer. MiRNAs in Aging and Cancer
265
308
.
Nages Nagaratnam, Kujan Nagaratnam & Gary CheukNages Nagaratnam, Kujan Nagaratnam & Gary Cheuk. 2017. Geriatric Diseases. Geriatric Diseases
1
5
.
Takamura Nagasaka & Yoshihisa Takiyama. 2015. Neurodegenerative Disorders as Systemic Diseases. Neurodegenerative Disorders as Systemic Diseases
237
275
.
U. E. Williams, E. E. Philip-Ephraim & S. K. Oparah. (2014) Multidisciplinary Interventions in Motor Neuron Disease. Journal of Neurodegenerative Diseases 2014, pages 1-10.
Crossref
Crossref
Jane Larkindale, Wenya Yang, Paul F. Hogan, Carol J. Simon, Yiduo Zhang, Anjali Jain, Elizabeth M. Habeeb-Louks, Annie Kennedy & Valerie A. Cwik. (2014) Cost of illness for neuromuscular diseases in the United States. Muscle & Nerve 49:3, pages 431-438.
Crossref
Crossref
Poul Jennum, Rikke Ibsen, Stephen Wørlich Pedersen & Jakob Kjellberg. (2012) Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study. Journal of Neurology 260:3, pages 785-793.
Crossref
Crossref
Geraldine Foley, Virpi Timonen & Orla Hardiman. (2011) Experience of Services as a Key Outcome in Amyotrophic Lateral Sclerosis (ALS) Care. American Journal of Hospice and Palliative Medicine® 29:5, pages 362-367.
Crossref
Crossref
Andrea Vianello, Giovanna Arcaro, Arianna Palmieri, Mario Ermani, Fausto Braccioni, Federico Gallan, Gianni Soraru'Elena Pegoraro. (2011) Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis. Journal of Critical Care 26:3, pages 329.e7-329.e14.
Crossref
Crossref
Richard S Bedlack. (2010) Amyotrophic lateral sclerosis: current practice and future treatments. Current Opinion in Neurology 23:5, pages 524-529.
Crossref
Crossref
Karsten Schepelmann, Yaroslav Winter, Annika E. Spottke, Detlef Claus, Christoph Grothe, Rolf Schröder, Dieter Heuss, Stefan Vielhaber, Veit Mylius, Reinhard Kiefer, Bertold Schrank, Wolfgang H. Oertel & Richard Dodel. (2009) Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. Journal of Neurology 257:1, pages 15-23.
Crossref
Crossref
Louisa Ng & Fary Khan. (2009) Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref